1-7 of 7
Andrew H. Ko
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Allogeneic GM-CSF–Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer

Annie A. Wu, Katherine M. Bever, Won Jin Ho, Elana J. Fertig, Nan Niu, Lei Zheng, Rose M. Parkinson, Jennifer N. Durham, Beth Onners, Anna K. Ferguson, Cara Wilt, Andrew H. Ko, Andrea Wang-Gillam, Daniel A. Laheru, Robert A. Anders, Elizabeth D. Thompson, Elizabeth A. Sugar, Elizabeth M. Jaffee, Dung T. Le
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (19): 5129–5139.
https://doi.org/10.1158/1078-0432.CCR-20-1025
Published: 01 October 2020
View article titled, A Phase II Study of Allogeneic GM-CSF–Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
Open the PDF for A Phase II Study of Allogeneic GM-CSF–Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Outcome

Manish A. Shah, Peter Enzinger, Andrew H. Ko, Allyson J. Ocean, Philip Agop Philip, Prashant V. Thakkar, Kyle Cleveland, Yao Lu, Jeremy Kortmansky, Paul J. Christos, Chao Zhang, Navjot Kaur, Dina Elmonshed, Giuseppe Galletti, Sandipto Sarkar, Bhavneet Bhinder, Meredith E. Pittman, Olga Mikhaylovna Plotnikova, Nikita Kotlov, Felix Frenkel, Aleksander Bagaev, Olivier Elemento, Doron Betel, Paraskevi Giannakakou, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18): 4756–4766.
https://doi.org/10.1158/1078-0432.CCR-19-3920
Published: 15 September 2020
View article titled, Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Outcome
Open the PDF for Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Outcome in another window
Journal Articles

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

Takahiro Tsujikawa, Todd Crocenzi, Jennifer N. Durham, Elizabeth A. Sugar, Annie A. Wu, Beth Onners, Julie M. Nauroth, Robert A. Anders, Elana J. Fertig, Daniel A. Laheru, Kim Reiss, Robert H. Vonderheide, Andrew H. Ko, Margaret A. Tempero, George A. Fisher, Michael Considine, Ludmila Danilova, Dirk G. Brockstedt, Lisa M. Coussens, Elizabeth M. Jaffee, Dung T. Le
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (14): 3578–3588.
https://doi.org/10.1158/1078-0432.CCR-19-3978
Published: 15 July 2020
View article titled, Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer
Open the PDF for Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)

Dung T. Le, Vincent J. Picozzi, Andrew H. Ko, Zev A. Wainberg, Hedy Kindler, Andrea Wang-Gillam, Paul Oberstein, Michael A. Morse, Herbert J. Zeh, III, Colin Weekes, Tony Reid, Erkut Borazanci, Todd Crocenzi, Noelle K. LoConte, Benjamin Musher, Dan Laheru, Aimee Murphy, Chan Whiting, Nitya Nair, Amanda Enstrom, Sandy Ferber, Dirk G. Brockstedt, Elizabeth M. Jaffee
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5493–5502.
https://doi.org/10.1158/1078-0432.CCR-18-2992
Published: 13 September 2019
View article titled, Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)
Open the PDF for Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study) in another window
Includes: Supplementary data
Journal Articles

New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints

Victoria E. Wang, Jennifer R. Grandis, Andrew H. Ko
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (17): 4283–4290.
https://doi.org/10.1158/1078-0432.CCR-16-0292
Published: 31 August 2016
View article titled, New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints
Open the PDF for New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints in another window
Journal Articles

A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

Andrew H. Ko, Tanios Bekaii-Saab, Jessica Van Ziffle, Olga M. Mirzoeva, Nancy M. Joseph, AmirAli Talasaz, Peter Kuhn, Margaret A. Tempero, Eric A. Collisson, R. Kate Kelley, Alan P. Venook, Elizabeth Dito, Anna Ong, Sharvina Ziyeh, Ryan Courtin, Regina Linetskaya, Sanaa Tahiri, W. Michael Korn
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1): 61–68.
https://doi.org/10.1158/1078-0432.CCR-15-0979
Published: 03 January 2016
View article titled, A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma
Open the PDF for A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies

Amy J. Chien, Julie A. Illi, Andrew H. Ko, Wolfgang M. Korn, Lawrence Fong, Lee-may Chen, Mohammed Kashani-Sabet, Charles J. Ryan, Jonathan E. Rosenberg, Sarita Dubey, Eric J. Small, Thierry M. Jahan, Nola M. Hylton, Benjamin M. Yeh, Yong Huang, Kevin M. Koch, Mark M. Moasser
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (17): 5569–5575.
https://doi.org/10.1158/1078-0432.CCR-09-0522
Published: 31 August 2009
View article titled, A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies
Open the PDF for A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies in another window